Inflammatory Bone Marrow Environment Blunts Daratumumab and Lenalidomide Efficacy in Myeloma
A multi-omic analysis reveals that coordinated NF-κB-driven inflammation across bone marrow immune and plasma cells impairs daratumumab and lenalidomide response ...






